Autoimmune Encephalitis Following Bone Marrow Transplantation - 24/08/15
, Kathryn S. Leung, MD b, Eyal Muscal, MD cAbstract |
Background |
Neurological complications, especially encephalopathy and seizures, are commonly seen in bone marrow transplant patients. Infections, chemotoxicity, graft versus host disease, or secondary central nervous system malignancies are the most common underlying etiologies. There is increased awareness that autoimmune encephalitis may cause neurological dysfunction in immunocompetent children. The potential role of such a mechanism in children undergoing bone marrow transplantation is unknown.
Methods |
We report a boy who developed autoimmune encephalitis with voltage-gated potassium channel–associated and thyroid autoantibodies subsequent to transplantation.
Results |
A 7-year-old boy presented with a change in behavior, poor attention, cognitive deficits, and abnormal movements 15 months after undergoing transplantation for idiopathic aplastic anemia. He had clinical and subclinical seizures and brain magnetic resonance imaging hyperintensities bilaterally in the uncal regions. His evaluation revealed high titers of voltage-gated potassium channel, leucine-rich glioma-inactivated 1 protein, and thyroglobulin antibodies suggestive of autoimmune limbic encephalitis. He showed significant improvement in behavior and neuropsychological testing and has remained seizure-free on levetiracetam after immunotherapy with corticosteroids and intravenous immunoglobulin.
Conclusion |
Systemic autoimmune manifestations in bone marrow transplant patients have been well-documented, but autoimmune encephalitis after transplantation has yet to be described in children.
Le texte complet de cet article est disponible en PDF.Keywords : limbic encephalitis, voltage-gated potassium channel (VGKC) associated antibody, leucine-rich glioma-inactivated 1 protein (LGI1), Hashimoto encephalopathy, cognitive changes in bone marrow transplant patients, autoimmune epilepsy
Plan
| Conflict of interest: None. |
Vol 53 - N° 3
P. 253-256 - septembre 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
